Abstract:Background: The high recurrence of a urethral stricture after direct vision internal urethrotomy (DVIU) has been a problem for years. Mitomycin C (MMC) is an excellent antifibrosis antigen that has been used in many fields, but its effect on a urethral stricture remains controversial. The purpose of this review was to investigate the effectiveness of MMC in reducing the recurrence rate of a urethral stricture after the first urethrotomy. Methods: Common databases were searched for publications prior to November 30, 2020. Randomized controlled and cohort trials were all included. Recurrence and success rates after the first urethrotomy of the posterior urethra were the main outcomes. Revman 5.3 was used for statistical analysis. Two evaluation systems, the Cochrane risk of bias tool and the Newcastle Ottawa Scale, were used to examine the risk of bias for RCTs and all studies. The quality of evidence was assessed by the Grading of Recommendations, Assessment, Development, and Evaluation standard. Results: Sixteen trials were included, the reporting quality of which was generally poor, and the evidence level was very low to moderate. The addition of MMC could significantly reduce the recurrence rate of urethral strictures (risk ratio [RR] = 0.42; 95% confidence interval [CI]: 0.26, 0.67; p = 0.0002; 9 trials; 550 participants). The results of the subgroup analysis suggested that the effect of MMC combined with DVIU was significant in short (≤2 cm) anterior urethral strictures (RR = 0.39; 95% CI: 0.20, 0.78; p = 0.008), >12-month follow-up (RR = 0.45; 95% CI: 0.26, 0.76; p = 0.003). It also increased the success rate of the first urethrotomy procedure for posterior urethral contracture (RR = 0.74; 95% CI: 0.65, 0.84; p < 0.00001; 7 trials; 342 participants). Low-dose local injection of MMC was the most commonly used method. Conclusion: MMC combined with DVIU is a promising way to reduce the long-term recurrence rate of a short-segment anterior urethral stricture. It also increases the success rate of the first urethrotomy of the posterior urethra. However, more high-quality randomized controlled trials are needed.

Effectiveness of mitomycin C in reducing reformation of adhesions following surgery for restrictive strabismus

Toxic effects of mitomycin C on cultured rabbit corneal endothelial cells

Long-Term Effects of Simultaneous Subconjunctival and Subscleral Mitomycin C Application in Repeat Trabeculectomy

Mitomycin and amniotic membrane: a new method of reducing adhesions and fibrosis in strabismus surgery

Corneal Relaxing Incision Combined with Phacoemulsification and IOL Implantation

Limbal Stem Cell Transplantation Combined with Mitomycin C in the Treatment of Recurrent Pterygium

Application of the Sodium Hyaluronate in Mitomycin C Trabeculectomy

Effects of intraoperative sponge mitomycin C and 5-fluorouracil on scar formation following strabismus surgery in rabbits

The Effect of Intraoperative Mitomycin C on Refractive Stability after Laser-Assisted Subepithelial Keratomileusis in Treating High Myopia

The Effect of Mitomycin C on the Corneal Endothelium and Corneal Posterior Surface after Laser Subepithelial Keratomileusis

Safety and Efficacy of Mitomycin C: Augmented Trabeculectomy: Subtenon's Injection versus Sponge Application

Surgical outcomes of trabeculectomy augmented with sub-Tenon injected mitomycin C

Effects of mitomycin-C on tear film, corneal biomechanics, and surface irregularity in mild to moderate myopic surface ablation: preliminary results

Adhesion reduction after knee surgery in a rat model by mitomycin C

The primary efficacy of trabeculectomy with immersion of mitomycin C and amniotic membrane implantation for refractory glaucoma

Efficacy of Mitomycin C Combined with Direct Vision Internal Urethrotomy for Urethral Strictures: A Systematic Review and Meta-Analysis

Efficacy of treatment for pterygium by autologous conjunctival transplantation and mitomycin C

Mitomycin C, amniotic membrane transplantation and limbal conjunctival autograft for treating multirecurrent pterygia with symblepharon and motility restriction

Pterygium recurrence following preoperative topical Mitomycin C and 5-Fluorouracil eyedrops

Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia

Biological effects of mitomycin C on late corneal haze stromal fibrosis following PRK